48.86

1.13% -0.56

After Hours: 48.86

Prestige Consumer Healthcare Inc (PBH)

Overview News Price History Option Chain Financials Discussions Forecast

Prestige Consumer Healthcare Inc stock is traded at $48.86, with a volume of 442.71K. It is down -1.13% in the last 24 hours and up +3.56% over the past month. Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Previous Close:

$49.42

Open:

$49.06

24h Volume:

442.71K

Relative Volume:

0.63

Market Cap:

$2.31B

Revenue:

$1.10B

Net Income/Loss:

$186.50M

P/E Ratio:

12.92

EPS:

3.7817

Net Cash Flow:

$267.19M

1W Performance:

+1.73%

1M Performance:

+3.56%

6M Performance:

-22.15%

1Y Performance:

-38.91%

1-Day Range:

$47.87

$49.25

1-Week Range:

$47.20

$49.56

52-Week Range:

$42.62

$80.30

Prestige Consumer Healthcare Inc Stock (PBH) Company Profile

Name

Prestige Consumer Healthcare Inc

Sector

Healthcare (1100)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

(914) 524-6800

Address

660 WHITE PLAINS RD., TARRYTOWN, NY

Employee

890

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

PBH's Discussions on Twitter

Compare PBH vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PBH Prestige Consumer Healthcare Inc	48.86	2.24B	1.10B	186.50M	267.19M	3.7817
TAK Takeda Pharmaceutical Co Adr	16.89	50.65B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.72	41.09B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	35.29	39.45B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	75.42	30.13B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	547.25	23.00B	3.17B	1.29B	1.01B	27.09

Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-24-25	Upgrade	Sidoti	Neutral → Buy
Dec-09-24	Downgrade	Sidoti	Buy → Neutral
Jun-21-24	Upgrade	DA Davidson	Neutral → Buy
Nov-17-22	Initiated	Canaccord Genuity	Buy
May-10-22	Upgrade	Jefferies	Hold → Buy
May-09-22	Upgrade	Oppenheimer	Perform → Outperform
Aug-07-20	Downgrade	DA Davidson	Buy → Neutral
Jun-29-20	Upgrade	Sidoti	Neutral → Buy
Apr-14-20	Downgrade	Jefferies	Buy → Hold
Apr-07-20	Resumed	Sidoti	Neutral
Mar-26-20	Upgrade	Jefferies	Hold → Buy
Mar-24-20	Initiated	Oppenheimer	Perform
Mar-19-20	Upgrade	DA Davidson	Neutral → Buy
Jan-15-19	Downgrade	Raymond James	Outperform → Mkt Perform
Dec-04-17	Upgrade	William Blair	Mkt Perform → Outperform
Jun-02-17	Upgrade	Jefferies	Underperform → Hold
May-22-17	Upgrade	Raymond James	Mkt Perform → Outperform
Dec-27-16	Reiterated	B. Riley & Co.	Buy
Nov-17-16	Initiated	Gabelli & Co	Buy
Aug-12-16	Upgrade	Sidoti	Neutral → Buy
Mar-08-16	Initiated	KeyBanc Capital Mkts	Overweight
Feb-05-16	Initiated	Piper Jaffray	Overweight
Nov-30-15	Downgrade	Jefferies	Hold → Underperform
Apr-28-14	Reiterated	B. Riley & Co.	Buy
Apr-28-14	Reiterated	Oppenheimer	Outperform
Jul-09-13	Initiated	B. Riley & Co.	Buy

View All

Prestige Consumer Healthcare Inc Stock (PBH) Latest News

Jul 01, 2026

Prestige Consumer Healthcare unit plans $400M notes offering - MSN

Jul 01, 2026

Jun 30, 2026

PBH | Prestige Consumer Healthcare Inc. Executive Compensation - Quiver Quantitative

Jun 30, 2026

Prestige Plans $400 Million Private Offering of Senior Notes - Moomoo

Jun 30, 2026

Prestige Consumer Healthcare (PBH) Announces $400M Senior Notes Offering - GuruFocus

Jun 30, 2026

Prestige Consumer Healthcare plans $400m notes offering - Investing.com

Jun 30, 2026

Prestige Consumer Healthcare plans $400m notes offering By Investing.com - Investing.com Canada

Jun 30, 2026

Prestige Consumer Healthcare Announces Proposed Private Offering of $400 Million Senior Notes Due 2034 to Redeem 2028 Notes - Quiver Quantitative

Jun 30, 2026

Prestige Consumer Healthcare Inc. Announces Offering Of $400 Million Senior Notes - TradingView

Jun 30, 2026

Prestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior Notes - GlobeNewswire

Jun 30, 2026

Prestige Consumer lines up $400M debt refinancing due 2034 - Stock Titan

Jun 30, 2026

[8-K/A] Prestige Consumer Healthcare Inc. Amends Material Event Report - Stock Titan

Jun 30, 2026

Jun 29, 2026